Nanotechnology targets cancer cells with dumbbell-like particles

By joining an iron oxide nanoparticle bearing a tumor-specific antibody with a gold nanoparticle bearing an anti-cancer drug, scientists created a dumbbell-like nanotech vehicle that delivered the drug into breast cancer cells. From Brown University, via AAAS EurekAlert “Twin nanoparticle shown effective at targeting, killing breast cancer cells“:

Breast cancer patients face many horrors, including those that arise when fighting the cancer itself. Medications given during chemotherapy can have wicked side effects, including vomiting, dizziness, anemia and hair loss. These side effects occur because medications released into the body target healthy cells as well as tumor cells.

The trick becomes how to deliver cancer-fighting drugs directly to the tumor cells. Brown University chemists think they have an answer: They have created a twin nanoparticle that specifically targets the Her-2-positive tumor cell, a type of malignant cell that affects up to 30 percent of breast cancer patients.

The combination nanoparticle binds to the Her-2 tumor cell and unloads the cancer-fighting drug cisplatin directly into the infected cell. The result: Greater success at killing the cancer while minimizing the anti-cancer drug’s side effects.

“Like a missile, you don’t want the anti-cancer drugs to explode everywhere,” explained Shouheng Sun, a chemistry professor at Brown University and an author on the paper published online in The Journal of the American Chemical Society [abstract]. “You want it to target the tumor cells and not the healthy ones.”

The researchers created the twin nanoparticle by binding one gold (Au) nanoparticle with an iron-oxide (Fe3O4) nanoparticle. On one end, they attached a synthetic protein antibody to the iron-oxide nanoparticle. On the other end, they attached cisplatin to the gold nanoparticle. Visually, the whole contraption looks like an elongated dumbbell, but it may be better to think of it as a vehicle, equipped with a very good GPS system, that is ferrying a very important passenger.

In this case, the GPS comes from the iron-oxide nanoparticle, which homes in on a Her-2 breast-cancer cell like a guided missile. The attached antibody is critical, because it binds to the antigen, a protein located on the surface on the malignant cell. Put another way, the nanoparticle vehicle “docks” on the tumor cell when the antibody and the antigen become connected. Once docked, the vehicle unloads its “passenger,” the cisplatin, into the malignant cell.

…The researchers will test the breast-cancer nanoparticle system in laboratory tests with animals. They also plan to create twin nanoparticles that can release the drug via remote-controlled magnetic heating.

There is no shortage of nanoparticles that appear promising as drug delivery vehicles, but much remains to be done to demonstrate successful therapies. (Credit: ScienceDaily)
—Jim

Leave a comment

0
    0
    Your Cart
    Your cart is emptyReturn to Shop